1. Home
  2. KVYO vs LEGN Comparison

KVYO vs LEGN Comparison

Compare KVYO & LEGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Klaviyo Inc. Series A

KVYO

Klaviyo Inc. Series A

HOLD

Current Price

$17.57

Market Cap

5.3B

Sector

N/A

ML Signal

HOLD

Logo Legend Biotech Corporation

LEGN

Legend Biotech Corporation

HOLD

Current Price

$20.54

Market Cap

5.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KVYO
LEGN
Founded
2012
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.3B
5.9B
IPO Year
2023
2020

Fundamental Metrics

Financial Performance
Metric
KVYO
LEGN
Price
$17.57
$20.54
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
21
12
Target Price
$34.48
$61.33
AVG Volume (30 Days)
5.9M
2.5M
Earning Date
05-05-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
35.29
N/A
EPS
N/A
N/A
Revenue
$1,234,019,000.00
N/A
Revenue This Year
$24.47
$42.68
Revenue Next Year
$19.66
$30.52
P/E Ratio
$657.67
N/A
Revenue Growth
31.63
N/A
52 Week Low
$12.53
$16.24
52 Week High
$36.23
$37.50

Technical Indicators

Market Signals
Indicator
KVYO
LEGN
Relative Strength Index (RSI) 49.82 42.46
Support Level $17.48 $20.21
Resistance Level $19.26 $21.58
Average True Range (ATR) 1.39 0.82
MACD -0.08 0.43
Stochastic Oscillator 48.37 57.84

Price Performance

Historical Comparison
KVYO
LEGN

About KVYO Klaviyo Inc. Series A

Klaviyo Inc is a technology company that provides a software-as-a-service (SaaS) platform to enable its customers to send the right messages at the right time across email, short message service, and push notifications, more accurately measure and predict performance, and deploy specific actions and campaigns. The platform combines proprietary data and application layers into one solution with machine learning and artificial intelligence capabilities. It is focused on marketing automation within eCommerce as its first application use case. It generates revenue through the sale of subscriptions to its customers for the use of its platform. Geographically, the company generates the majority of its revenue from the Americas, followed by EMEA and APAC.

About LEGN Legend Biotech Corporation

Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.

Share on Social Networks: